Monashee Investment Management LLC Blueprint Medicines Corp Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$73.54 - $97.8 $10.2 Million - $13.5 Million	-138,500 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$48.7 - $86.6 $6.74 Million - $12 Million	138,500 New	138,500 $11.1 Million
Q1 2018 May 10, 2018	SELL	$73.28 - $102.95 $6.98 Million - $9.8 Million	-95,195 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$62.91 - $88.32 $5.99 Million - $8.41 Million	95,195	95,195 $7.18 Million

380

65.9M

1.6M

1.41M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.51B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.